Cargando…
Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review
BACKGROUND: Appraisals of Vogt-Koyanagi-Harada disease (VKH) have become progressively more complete, since its first description in 1906. The availability of new investigational methods has improved our knowledge of the immunopathology, clinicopathology, diagnosis, and management of VKH disease. Th...
Autores principales: | Urzua, Cristhian A., Herbort, Carl P., Takeuchi, Masaru, Schlaen, Ariel, Concha-del-Rio, Luz E., Usui, Yoshihiko, Cuitino, Loreto, Papasavvas, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098759/ https://www.ncbi.nlm.nih.gov/pubmed/35553272 http://dx.doi.org/10.1186/s12348-022-00293-3 |
Ejemplares similares
-
miRNA Landscape in Pathogenesis and Treatment of Vogt–Koyanagi–Harada Disease
por: Vega-Tapia, Fabian, et al.
Publicado: (2021) -
Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease
por: Urzua, Cristhian A., et al.
Publicado: (2020) -
“Revised diagnostic criteria” for Vogt-Koyanagi-Harada disease fail to improve disease management
por: Hedayatfar, Alireza, et al.
Publicado: (2018) -
Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: A multicenter study
por: Takeuchi, Masaru, et al.
Publicado: (2022) -
Indocyanine Green Angiography Guided Management of Vogt-Koyanagi-Harada Disease
por: Bouchenaki, Nadia, et al.
Publicado: (2011)